Physician

Andrew Stephen Delmas, MD

According to 2025 Medicare claims, Andrew Delmas, MD (NPI: 1750582672) practices medical oncology, with the plurality of this provider's patient population coming from Rutherford, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1508135799; TIN: 56-0529945) and primary practice location at 28043-9021. Delmas is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Delmas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 232 traditional Medicare patients, billed 609 HCPCS/CPT codes, and received $36,499 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,305 prescription claims across 212 beneficiaries totaling $3,446,173 in drug costs, led by Imbruvica (Ibrutinib). Open Payments data shows 2 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $428,544 to $3,446,173. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$26K$52K2020 Medicare payment: $16,875 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $48,143 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $51,554 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $47,666 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $36,499 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020174310$16,875
2021267779$48,143
2022277768$51,554
2023269746$47,666
2024232609$36,499

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.4M2020 Drug cost: $428,544 (USD; Tot_Drug_Cst)2021 Drug cost: $2,297,690 (USD; Tot_Drug_Cst)2022 Drug cost: $2,718,153 (USD; Tot_Drug_Cst)2023 Drug cost: $3,156,607 (USD; Tot_Drug_Cst)2024 Drug cost: $3,446,173 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202072218$428,544
20211621,013$2,297,690
20221781,139$2,718,153
20231961,185$3,156,607
20242121,305$3,446,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1919$130
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2226$105
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more1717$77
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more109293$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more141217$40

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib561,628$601,541
PomalystPomalidomide18504$417,577
CalquenceAcalabrutinib Maleate28840$403,779
JakafiRuxolitinib Phosphate21630$356,274
KisqaliRibociclib Succinate26700$305,650

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$50Adaptive Biotechnologies Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Stephen Delmas, MD?

Tedicare shows public-source Medicare data for Andrew Stephen Delmas, MD (NPI 1750582672), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Stephen Delmas, MD have ACO affiliation data?

Andrew Stephen Delmas, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Andrew Stephen Delmas, MD?

Andrew Stephen Delmas, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1508135799) in the available physician profile data.

Does Andrew Stephen Delmas, MD have Open Payments data?

Andrew Stephen Delmas, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.